Log In
BCIQ
Print this Print this
 

Adenosine A3 receptor (ADORA3)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Adenosine A3 receptor (ADORA3)

BCIQ
Print ChartPrint this
2 1 1 0 1 0 0 0 1 0 0 0 0 0 1 0 1 1 1 1
Phases of DevelopmentPreclinicalPhase IPhase IIPhase II/III
Autoimmune

1

1

1

1

Cancer

0

0

1

0

Genitourinary

1

0

0

0

Inflammation

1

0

0

0

Ophthalmic

2

1

1

0




 Products Targeting Adenosine A3 receptor (ADORA3)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$2.9M

$1.3M

$2.8M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today